Robust anti-tumor immunity through the integration of targeted lipid nanoparticle-based mRNA nanovaccines with PD-1/PD-L1 blockade

ABSTRACT:

SUBMITTER: Jin C 

PROVIDER: S-EPMC11251012 | biostudies-literature | 2024 Jun

REPOSITORIES: biostudies-literature